IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Tomasini, Davide
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.598
AS - Asia 1.231
EU - Europa 959
SA - Sud America 208
Continente sconosciuto - Info sul continente non disponibili 56
AF - Africa 34
OC - Oceania 3
Totale 5.089
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.510
SG - Singapore 474
IT - Italia 336
CN - Cina 299
BR - Brasile 175
DE - Germania 161
HK - Hong Kong 145
VN - Vietnam 92
GB - Regno Unito 63
FI - Finlandia 60
PL - Polonia 60
UA - Ucraina 56
FR - Francia 55
BD - Bangladesh 53
TR - Turchia 49
IN - India 45
RU - Federazione Russa 43
CA - Canada 36
IE - Irlanda 30
NL - Olanda 18
ID - Indonesia 16
MX - Messico 15
CZ - Repubblica Ceca 14
SE - Svezia 13
AR - Argentina 12
ES - Italia 12
IQ - Iraq 12
ZA - Sudafrica 11
JM - Giamaica 8
TN - Tunisia 8
JP - Giappone 7
MA - Marocco 7
EG - Egitto 6
GT - Guatemala 6
AT - Austria 5
CH - Svizzera 5
CO - Colombia 5
LT - Lituania 5
AL - Albania 4
EC - Ecuador 4
EE - Estonia 4
HN - Honduras 4
IL - Israele 4
PK - Pakistan 4
AU - Australia 3
BO - Bolivia 3
JO - Giordania 3
LV - Lettonia 3
OM - Oman 3
PR - Porto Rico 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BE - Belgio 2
BZ - Belize 2
CR - Costa Rica 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
GP - Guadalupe 2
GR - Grecia 2
KZ - Kazakistan 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
SV - El Salvador 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CL - Cile 1
DK - Danimarca 1
EU - Europa 1
GD - Grenada 1
IR - Iran 1
IS - Islanda 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
NI - Nicaragua 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 5.036
Salva come PNG Salva come JPEG
Città #
Ashburn 319
Singapore 266
San Jose 211
Fairfield 182
Chandler 158
Hong Kong 144
Los Angeles 92
New York 90
Beijing 78
Council Bluffs 75
Seattle 75
Woodbridge 69
Houston 68
Wilmington 62
Brescia 61
Munich 60
Warsaw 56
The Dalles 52
Jacksonville 50
Cambridge 48
Milan 48
Princeton 46
Dallas 45
Helsinki 43
Ho Chi Minh City 39
Lauterbourg 32
Dublin 30
Istanbul 30
Shanghai 30
Santa Clara 29
North Bergen 26
Chicago 23
Columbus 21
Buffalo 19
Phoenix 19
São Paulo 19
Frankfurt am Main 18
Ann Arbor 16
Des Moines 16
San Diego 16
San Francisco 15
Boardman 13
Hanoi 13
Jakarta 13
Denver 12
Nuremberg 12
Orem 12
Redondo Beach 12
Rome 11
Turku 11
Washington 11
Brno 10
Dong Ket 10
London 10
Romola 10
Toronto 10
Atlanta 9
Chennai 9
Montreal 9
Naples 9
Brooklyn 8
Moscow 8
Dearborn 7
Rio de Janeiro 7
Tokyo 7
Bologna 6
Catania 6
Erbil 6
Guangzhou 6
Johannesburg 6
Kingston 6
Lappeenranta 6
Lumezzane 6
Mexico City 6
New Delhi 6
Philadelphia 6
Poplar 6
Amsterdam 5
Bengaluru 5
Boston 5
Changsha 5
Cremona 5
Düsseldorf 5
Kyiv 5
Manchester 5
Salt Lake City 5
Ankara 4
Brasília 4
Cairo 4
Delhi 4
Haiphong 4
Miami 4
Nanjing 4
Nashville 4
Paris 4
Porto Alegre 4
Tianjin 4
Tirana 4
Athens 3
Augusta 3
Totale 3.210
Salva come PNG Salva come JPEG
Nome #
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 240
Metabolic behavior and prognostic role of pretreatment 18F-FDG PET/CT in gist 216
Intra-fraction and Inter-fraction analysis of a dedicated immobilization device for intracranial radiation treatment 185
Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete response 181
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma 174
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 172
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 171
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 168
18F-Fluciclovine (18F-FACBC) PET/CT or PET/MRI in gliomas/glioblastomas 166
Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis 158
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways 152
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 152
18F-FDG PET or PET/CT role in plasmacytoma: A systematic review 151
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 150
Low-dose Lung Radiotherapy for COVID-19-related Pneumonia: Preliminary Results of the Italian Mono-institutional COLOR-19 Trial 147
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group 147
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial 146
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 146
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients 142
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience 139
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 137
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study 122
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment 122
Letter to the editor regarding “Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable” 119
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients 111
Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy 111
Impact of Dosimetric Parameters on Tumor Control in Stereotactic Radiotherapy for Pancreatic Cancer: A Prospective Study on 104 Patients Treated with Simultaneous Integrated Protection (SIP) 110
Prevention and management of acute esophageal toxicity during concomitant chemoradiotherapy for locally advanced lung cancer 110
Post-HIFU locally relapsed prostate cancer: high-dose salvage radiotherapy guided by molecular imaging 109
Treatment of loco-regional recurrence of nasopharyngeal carcinoma in a non-endemic area: oncologic outcomes, morbidity, and proposal of a prognostic nomogram 103
High dose proton and photon-based radiation therapy for 213 liver lesions: a multi-institutional dosimetric comparison with a clinical perspective 103
Sparing of swallowing-related organs in radiotherapy for oropharyngeal squamous cell carcinoma 103
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience 100
Radiolabelled PSMA PET/CT in breast cancer. A systematic review 100
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in response to Onal's letter to the editor 86
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 79
Stereotactic Radiotherapy and Androgen Deprivation Therapy for Localized Prostate Cancer: A Retrospective Mono-institutional Experience 61
Totale 5.089
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.694
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022169 0 0 0 9 4 15 10 13 12 31 11 64
2022/2023404 38 18 18 32 47 80 12 46 60 3 33 17
2023/2024483 31 8 59 22 22 90 27 32 84 20 20 68
2024/2025879 15 19 18 132 65 88 60 38 107 71 167 99
2025/20261.838 183 207 118 242 198 130 259 70 112 153 93 73
2026/2027481 64 54 104 259 0 0 0 0 0 0 0 0
Totale 5.089